Exercise preconditioning prevents MCT-induced right ventricle remodeling through the regulation of TNF superfamily cytokines

International Journal of Cardiology

Volumn 203, Issue , 2016, Pages 858-866

  Nogueira Ferreira, Rita ^a,b   Moreira Gonçalves, Daniel ^b,c   Silva, Ana Filipa ^b   Duarte, José Alberto ^c   Leite Moreira, Adelino ^b,d   Ferreira, Rita ^a   Henriques Coelho, Tiago ^b  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b University of Porto   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Exercise training; Heart failure; Pro inflammatory cytokines; Pulmonary arterial hypertension; Right ventricle muscle

Indexed keywords

ATROGIN 1; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; MONOCROTALINE; TUMOR NECROSIS FACTOR; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; EXERCISE PRECONDITIONING; HEART INFARCTION PREVENTION; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY HYPERTENSION; RAT; SIGNAL TRANSDUCTION; THERAPY EFFECT; TREADMILL EXERCISE; TREATMENT RESPONSE; ANIMAL; CARDIAC MUSCLE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; EXERCISE; HEART RIGHT VENTRICLE FUNCTION; KINESIOTHERAPY; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVENTION AND CONTROL; PROCEDURES; WISTAR RAT;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; EXERCISE THERAPY; MALE; MONOCROTALINE; MYOCARDIUM; PHYSICAL EXERTION; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR REMODELING;

EID: 84952845514     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.11.066     Document Type: Article

References (46)

1. H.J. Bogaard, K. Abe, A. Vonk Noordegraaf, and N.F. Voelkel The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension Chest 135 2009 794 804
2. J.I. Drake, H.J. Bogaard, S. Mizuno, B. Clifton, B. Xie, Y. Gao, and et al. Molecular signature of a right heart failure program in chronic severe pulmonary hypertension Am J Respir Cell Mol Biol 45 2011 1239 1247
3. J. Gomez-Arroyo, S. Mizuno, K. Szczepanek, B. Van Tassell, R. Natarajan, C.G. dos Remedios, and et al. Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension Circ Heart Fail 6 2013 136 144
4. A. Vonk-Noordegraaf, F. Haddad, K.M. Chin, P.R. Forfia, S.M. Kawut, J. Lumens, and et al. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology J Am Coll Cardiol 62 2013 D22 D33
5. J.A. Watts, M.A. Gellar, M. Obraztsova, J.A. Kline, and J. Zagorski Role of inflammation in right ventricular damage and repair following experimental pulmonary embolism in rats Int J Exp Pathol 89 2008 389 399
6. A. Belhaj, L. Dewachter, F. Kerbaul, S. Brimioulle, C. Dewachter, R. Naeije, and et al. Heme oxygenase-1 and inflammation in experimental right ventricular failure on prolonged overcirculation-induced pulmonary hypertension PLoS One 8 2013 e69470
7. B. Rondelet, C. Dewachter, F. Kerbaul, X. Kang, P. Fesler, S. Brimioulle, and et al. Prolonged overcirculation-induced pulmonary arterial hypertension as a cause of right ventricular failure Eur Heart J 33 2012 1017 1026
8. J.A. Watts, J. Zagorski, M.A. Gellar, B.G. Stevinson, and J.A. Kline Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats J Mol Cell Cardiol 41 2006 296 307
9. M.E. Campian, M. Hardziyenka, K. de Bruin, B.L. van Eck-Smit, J.M. de Bakker, H.J. Verberne, and et al. Early inflammatory response during the development of right ventricular heart failure in a rat model Eur J Heart Fail 12 2010 653 658
10. J. Meloche, S. Renard, S. Provencher, and S. Bonnet Anti-inflammatory and immunosuppressive agents in PAH Handb Exp Pharmacol 218 2013 437 476
11. M.C. Chaumais, B. Ranchoux, D. Montani, P. Dorfmuller, L. Tu, F. Lecerf, and et al. N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats Respir Res 15 2014 65
12. M. Rabinovitch, C. Guignabert, M. Humbert, and M.R. Nicolls Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension Circ Res 115 2014 165 175
13. A.S. Babu, R. Padmakumar, and A.G. Maiya A review of ongoing trials in exercise based rehabilitation for pulmonary arterial hypertension Indian J Med Res 137 2013 900 906
14. D. Moreira-Goncalves, T. Henriques-Coelho, H. Fonseca, R.M. Ferreira, F. Amado, A. Leite-Moreira, and et al. Moderate exercise training provides left ventricular tolerance to acute pressure overload Am J Physiol Heart Circ Physiol 300 2011 H1044 H1052
15. R. Ferreira, D. Moreira-Goncalves, A.L. Azevedo, J.A. Duarte, F. Amado, and R. Vitorino Unraveling the exercise-related proteome signature in heart Basic Res Cardiol 110 2015 454
16. S.K. Powers, A.J. Smuder, A.N. Kavazis, and J.C. Quindry Mechanisms of exercise-induced cardioprotection Physiology (Bethesda) 29 2014 27 38
17. Q. Wang, X.R. Zuo, Y.Y. Wang, W.P. Xie, H. Wang, and M. Zhang Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-alpha antagonists via the suppression of TNF-alpha expression and NF-kappaB pathway in rats Vascul Pharmacol 58 2013 71 77
18. I. Falcao-Pires, G. Palladini, N. Goncalves, J. van der Velden, D. Moreira-Goncalves, D. Miranda-Silva, and et al. Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload Basic Res Cardiol 106 2011 801 814
19. R.J. Talmadge, and R.R. Roy Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms J Appl Physiol (1985) 75 1993 2337 2340
20. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
21. R. Vitorino, A. Barros, A. Caseiro, P. Domingues, J. Duarte, and F. Amado Towards defining the whole salivary peptidome Proteomics Clin Appl 3 2009 528 540
22. P. Bonaldo, and M. Sandri Cellular and molecular mechanisms of muscle atrophy Dis Model Mech 6 2013 25 39
23. T. Novoyatleva, A. Sajjad, and F.B. Engel TWEAK-Fn14 cytokine-receptor axis: a new player of myocardial remodeling and cardiac failure Front Immunol 5 2014 50
24. C. Freund, R. Schmidt-Ullrich, A. Baurand, S. Dunger, W. Schneider, P. Loser, and et al. Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo Circulation 111 2005 2319 2325
25. T.G. Schips, A. Wietelmann, K. Hohn, S. Schimanski, P. Walther, T. Braun, and et al. FoxO3 induces reversible cardiac atrophy and autophagy in a transgenic mouse model Cardiovasc Res 91 2011 587 597
26. T. Henriques-Coelho, J. Correia-Pinto, R. Roncon-Albuquerque Jr., M.J. Baptista, A.P. Lourenco, S.M. Oliveira, and et al. Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension Am J Physiol Heart Circ Physiol 287 2004 H2885 H2890
27. T. Henriques-Coelho, R. Roncon-Albuquerque Junior, A.P. Lourenco, M.J. Baptista, S.M. Oliveira, A. Brandao-Nogueira, and et al. Ghrelin reverses molecular, structural and hemodynamic alterations of the right ventricle in pulmonary hypertension Rev Port Cardiol 25 2006 55 63
28. I. Falcao-Pires, N. Goncalves, T. Henriques-Coelho, D. Moreira-Goncalves, R. Roncon-Albuquerque Jr., and A.F. Leite-Moreira Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension Am J Physiol Heart Circ Physiol 296 2009 H2007 H2014
29. J. Correia-Pinto, T. Henriques-Coelho, R. Roncon-Albuquerque Jr., A.P. Lourenco, G. Melo-Rocha, F. Vasques-Novoa, and et al. Time course and mechanisms of left ventricular systolic and diastolic dysfunction in monocrotaline-induced pulmonary hypertension Basic Res Cardiol 104 2009 535 545
30. T. Henriques-Coelho, S.M. Oliveira, R.S. Moura, R. Roncon-Albuquerque Jr., A.L. Neves, M. Santos, and et al. Thymulin inhibits monocrotaline-induced pulmonary hypertension modulating interleukin-6 expression and suppressing p38 pathway Endocrinology 149 2008 4367 4373
31. A.P. Lourenco, R. Roncon-Albuquerque Jr., C. Bras-Silva, B. Faria, J. Wieland, T. Henriques-Coelho, and et al. Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats Am J Physiol Heart Circ Physiol 291 2006 H1587 H1594
32. P.A. Harvey, and L.A. Leinwand The cell biology of disease: cellular mechanisms of cardiomyopathy J Cell Biol 194 2011 355 365
33. S.P. Barry, S.M. Davidson, and P.A. Townsend Molecular regulation of cardiac hypertrophy Int J Biochem Cell Biol 40 2008 2023 2039
34. P. Balakumar, and G. Jagadeesh Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared? Pharmacol Res 62 2010 365 383
35. M. Jasiewicz, K. Kowal, O. Kowal-Bielecka, M. Knapp, R. Skiepko, A. Bodzenta-Lukaszyk, and et al. Serum levels of CD163 and TWEAK in patients with pulmonary arterial hypertension Cytokine 66 2014 40 45
36. A. Filusch, T. Zelniker, C. Baumgartner, S. Eschricht, N. Frey, H.A. Katus, and et al. Soluble TWEAK predicts hemodynamic impairment and functional capacity in patients with pulmonary arterial hypertension Clin Res Cardiol 100 2011 879 885
37. A. Rohini, N. Agrawal, C.N. Koyani, and R. Singh Molecular targets and regulators of cardiac hypertrophy Pharmacol Res 61 2010 269 280
38. S. Gaspar-Pereira, N. Fullard, P.A. Townsend, P.S. Banks, E.L. Ellis, C. Fox, and et al. The NF-kappaB subunit c-Rel stimulates cardiac hypertrophy and fibrosis Am J Pathol 180 2012 929 939
39. K. Van der Heiden, S. Cuhlmann, A. Luong le, M. Zakkar, and P.C. Evans Role of nuclear factor kappaB in cardiovascular health and disease Clin Sci (Lond) 118 2010 593 605
40. T. Zaglia, G. Milan, A. Ruhs, M. Franzoso, E. Bertaggia, N. Pianca, and et al. Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy J Clin Invest 124 2014 2410 2424
41. D. Zhang, X. Liu, X. Chen, J. Gu, F. Li, W. Zhang, and et al. Role of the MAPKs/TGF-beta1/TRAF6 signaling pathway in atrial fibrosis of patients with chronic atrial fibrillation and rheumatic mitral valve disease Cardiology 129 2014 216 223
42. V. Adams, A. Linke, U. Wisloff, C. Doring, S. Erbs, N. Krankel, and et al. Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: effect on myocardial contractility Cardiovasc Res 73 2007 120 129
43. Y.Y. Li, T. Kadokami, P. Wang, C.F. McTiernan, and A.M. Feldman MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure Am J Physiol Heart Circ Physiol 282 2002 H983 H989
44. M. Okada, R. Kikuzuki, T. Harada, Y. Hori, H. Yamawaki, and Y. Hara Captopril attenuates matrix metalloproteinase-2 and -9 in monocrotaline-induced right ventricular hypertrophy in rats J Pharmacol Sci 108 2008 487 494
45. Z. Safdar, E. Tamez, W. Chan, B. Arya, Y. Ge, A. Deswal, and et al. Circulating collagen biomarkers as indicators of disease severity in pulmonary arterial hypertension JACC Heart Fail 2 2014 412 421
46. M. Bellafiore, G. Battaglia, A. Bianco, F. Farina, A. Palma, and A. Paoli The involvement of MMP-2 and MMP-9 in heart exercise-related angiogenesis J Transl Med 11 2013 283